Treatment of Urticarial Angioedema

First-Line Treatment Approach

The American Academy of Allergy, Asthma, and Immunology recommends starting with a single second-generation H1-antihistamine at standard dosing for 2-4 weeks to assess initial response 1
Second-generation antihistamines are the mainstay of therapy for both acute and chronic urticaria with angioedema, with over 40% of patients showing good response to antihistamines alone 2
Cetirizine is a preferred agent due to its shortest time to maximum concentration, advantageous for rapid symptom relief 3

If standard dosing provides inadequate control after 2-4 weeks, increase the antihistamine dose up to 4 times the standard dose 1

Add H2-antihistamines (ranitidine or famotidine) for resistant cases 1, 2
Add leukotriene receptor antagonists (montelukast) as adjunctive therapy, particularly beneficial for aspirin-sensitive and autoimmune urticaria 1, 2

Use short courses of oral corticosteroids only for severe acute urticaria or life-threatening angioedema (e.g., prednisolone 50 mg daily for 3 days in adults, or 3-10 days maximum) 1, 2
Restrict corticosteroid courses to 3-4 weeks maximum 2
Avoid long-term corticosteroid use in chronic urticaria except in very selected cases under specialist supervision due to cumulative toxicity 1, 3

Administer intramuscular epinephrine immediately for anaphylaxis or severe laryngeal angioedema 4, 3
Adult/adolescent dose: 0.5 mL of 1:1000 (500 µg) epinephrine intramuscularly 4

Consider omalizumab 300 mg subcutaneously every 4 weeks for severe antihistamine-resistant chronic urticaria 1
Cyclosporine 4 mg/kg daily is effective in approximately two-thirds of patients with severe autoimmune urticaria 4, 1

Avoid aspirin and NSAIDs in urticaria patients, as they inhibit cyclooxygenase and can exacerbate symptoms 2
Avoid ACE inhibitors in patients with angioedema without wheals, and use cautiously when angioedema accompanies urticaria 2

Minimize non-specific aggravating factors including overheating, stress, and alcohol 1
Apply cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) for symptomatic relief 1

Regularly assess disease activity, impact on quality of life, and treatment response 1
Consider stepping down therapy after achieving complete control for at least 3 consecutive months 1